Cargando…

trans-Resveratrol Ameliorates Stress-Induced Irritable Bowel Syndrome-Like Behaviors by Regulation of Brain-Gut Axis

Background: Irritable bowel syndrome (IBS) is a functional disorder characterized by abdominal pain and abnormalities in defecation associated with psychiatric disorders such as depression and anxiety due to the dysfunction of brain-gut axis. This study aims to determine whether trans-Resveratrol af...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Ying, Cui, Su-Ying, Ma, Quan, Shi, Jing, Yu, Ying, Li, Jian-Xin, Zheng, Liang, Zhang, Yi, Si, Jian-Min, Yu, Ying-Cong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013570/ https://www.ncbi.nlm.nih.gov/pubmed/29962949 http://dx.doi.org/10.3389/fphar.2018.00631

Ejemplares similares

Resveratrol Improves Brain-Gut Axis by Regulation of 5-HT-Dependent Signaling in the Rat Model of Irritable Bowel Syndrome
por: Yu, Ying-Cong, et al.
Publicado: (2019)

Ameliorative effect and mechanism of Si-Ni-San on chronic stress-induced diarrhea-irritable bowel syndrome in rats
por: Chen, Hui-Yu, et al.
Publicado: (2022)

Global trends in research on irritable bowel syndrome and the brain–gut axis: Bibliometrics and visualization analysis
por: Wu, Peng-Ning, et al.
Publicado: (2022)

Effects of Chang-Kang-Fang Formula on the Microbiota-Gut-Brain Axis in Rats With Irritable Bowel Syndrome
por: Ling, Xiwen, et al.
Publicado: (2022)

Resveratrol Modulates the Gut Microbiota and Inflammation to Protect Against Diabetic Nephropathy in Mice
por: Cai, Ting-Ting, et al.
Publicado: (2020)

Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome
por: Chen, Minjia, et al.
Publicado: (2022)

Pharmacokinetic Differences of Wuji Pill Components in Normal and Chronic Visceral Hypersensitivity Irritable Bowel Syndrome Rats Attributable to Changes in Tight Junction and Transporters
por: Gong, Zipeng, et al.
Publicado: (2022)

Epidemiology, Clinical Features, and Prescribing Patterns of Irritable Bowel Syndrome in Taiwan
por: Lai, Yu-Tung, et al.
Publicado: (2021)

Patchouli alcohol improved diarrhea-predominant irritable bowel syndrome by regulating excitatory neurotransmission in the myenteric plexus of rats
por: Chen, Wanyu, et al.
Publicado: (2022)

Sex-Bias in Irritable Bowel Syndrome: Linking Steroids to the Gut-Brain Axis
por: So, Sik Yu, et al.
Publicado: (2021)

Intestinal microbiome-gut-brain axis and irritable bowel syndrome
por: Moser, Gabriele, et al.
Publicado: (2017)

Systematic review and meta-analysis of Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: Evidence for clinical practice and future trials
por: Liang, Shi-Bing, et al.
Publicado: (2022)

Resveratrol Ameliorates Glucocorticoid-Induced Bone Damage in a Zebrafish Model
por: Luo, Qun, et al.
Publicado: (2019)

Tong-Xie-Yao-Fang Regulates 5-HT Level in Diarrhea Predominant Irritable Bowel Syndrome Through Gut Microbiota Modulation
por: Li, Junchen, et al.
Publicado: (2018)

Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome
por: Hillestad, Eline Margrete Randulff, et al.
Publicado: (2022)

Sini Decoction Ameliorates Colorectal Cancer and Modulates the Composition of Gut Microbiota in Mice
por: Wang, Yishan, et al.
Publicado: (2021)

Corrigendum: Resveratrol Ameliorates Glucocorticoid-Induced Bone Damage in a Zebrafish Model
por: Luo, Qun, et al.
Publicado: (2019)

Baihe Jizihuang Tang Ameliorates Chronic Unpredictable Mild Stress-Induced Depression-Like Behavior: Integrating Network Pharmacology and Brain-Gut Axis Evaluation
por: Zhu, Jian-ping, et al.
Publicado: (2021)

Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome
por: Mei, Lijun, et al.
Publicado: (2021)

The gut-lung axis: Gut microbiota changes associated with pulmonary fibrosis in mouse models induced by bleomycin
por: Quan, Yunyun, et al.
Publicado: (2022)

An Integrated Gut Microbiota and Network Pharmacology Study on Fuzi-Lizhong Pill for Treating Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhen, Zhang, et al.
Publicado: (2021)

Metformin Affects Gut Microbiota Composition and Diversity Associated with Amelioration of Dextran Sulfate Sodium-Induced Colitis in Mice
por: Liu, Zhiyi, et al.
Publicado: (2021)

The Ameliorative Effects of Isorhynchophylline on Morphine Dependence Are Mediated Through the Microbiota-Gut-Brain Axis
por: Chen, Zhu, et al.
Publicado: (2021)

The Role of Gut Microbiota—Gut—Brain Axis in Perioperative Neurocognitive Dysfunction
por: Lu, Jian, et al.
Publicado: (2022)

The Effective Role of Natural Product Berberine in Modulating Oxidative Stress and Inflammation Related Atherosclerosis: Novel Insights Into the Gut-Heart Axis Evidenced by Genetic Sequencing Analysis
por: Cao, Richard Y., et al.
Publicado: (2021)

Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
por: Colomier, Esther, et al.
Publicado: (2021)

An Overview of Systematic Reviews of Herbal Medicine for Irritable Bowel Syndrome
por: Jun, Hyejin, et al.
Publicado: (2022)

Chlorogenic Acid Ameliorates Post‐Infectious Irritable Bowel Syndrome by Regulating Extracellular Vesicles of Gut Microbes
por: Zheng, Cihua, et al.
Publicado: (2023)

Utilization patterns and prescription characteristics of traditional Chinese medicine among patients with irritable bowel syndrome in Taiwan
por: Gu, Ye, et al.
Publicado: (2023)

Wuji Wan Formula Ameliorates Diarrhea and Disordered Colonic Motility in Post-inflammation Irritable Bowel Syndrome Rats by Modulating the Gut Microbiota
por: Chen, Ying, et al.
Publicado: (2017)

Polysaccharide, the Active Component of Dendrobium officinale, Ameliorates Metabolic Hypertension in Rats via Regulating Intestinal Flora-SCFAs-Vascular Axis
por: Li, Bo, et al.
Publicado: (2022)

Resveratrol Promotes Diabetic Wound Healing via SIRT1-FOXO1-c-Myc Signaling Pathway-Mediated Angiogenesis
por: Huang, Xiaozhong, et al.
Publicado: (2019)

Drug Development for the Irritable Bowel Syndrome: Current Challenges and Future Perspectives
por: De Ponti, Fabrizio
Publicado: (2013)

Novel insights which may translate into treatments for irritable bowel syndrome
por: Izzo, Angelo A.
Publicado: (2013)

A Distinct Profile of Tryptophan Metabolism along the Kynurenine Pathway Downstream of Toll-Like Receptor Activation in Irritable Bowel Syndrome
por: Clarke, Gerard, et al.
Publicado: (2012)

Amelioration of AOM/DSS-Induced Murine Colitis-Associated Cancer by Evodiamine Intervention is Primarily Associated with Gut Microbiota-Metabolism-Inflammatory Signaling Axis
por: Wang, Mengxia, et al.
Publicado: (2021)

Efficacy and safety of fecal microbiota transplantation for the treatment of irritable bowel syndrome: an overview of overlapping systematic reviews
por: Zhang, Di, et al.
Publicado: (2023)

Resveratrol on the Metabolic Reprogramming in Liver: Implications for Advanced Atherosclerosis
por: Ma, Ying, et al.
Publicado: (2021)

Low FODMAP Diet and Probiotics in Irritable Bowel Syndrome: A Systematic Review With Network Meta-analysis
por: Xie, Chao-Rong, et al.
Publicado: (2022)

Fibromyalgia and Irritable Bowel Syndrome Interaction: A Possible Role for Gut Microbiota and Gut-Brain Axis
por: Garofalo, Cinzia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pgscq43voeq150hhpjtsff4fbh